Labcorp Holdings, Inc. (LH)
315.48
+3.33
(+1.07%)
USD |
NYSE |
Oct 12, 10:17
Labcorp Holdings Free Cash Flow (Quarterly) : 313.90M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 313.90M |
| March 31, 2026 | 70.50M |
| December 31, 2025 | 490.30M |
| September 30, 2025 | 280.50M |
| June 30, 2025 | 542.70M |
| March 31, 2025 | -107.50M |
| December 31, 2024 | 665.10M |
| September 30, 2024 | 161.50M |
| June 30, 2024 | 432.90M |
| March 31, 2024 | -163.60M |
| December 31, 2023 | 412.40M |
| September 30, 2023 | 170.60M |
| June 30, 2023 | 248.10M |
| March 31, 2023 | 43.00M |
| December 31, 2022 | 554.50M |
| September 30, 2022 | 291.00M |
| June 30, 2022 | 442.30M |
| March 31, 2022 | 238.80M |
| December 31, 2021 | 547.50M |
| September 30, 2021 | 649.50M |
| June 30, 2021 | 390.00M |
| March 31, 2021 | 1.062B |
| December 31, 2020 | 675.20M |
| September 30, 2020 | 709.00M |
| June 30, 2020 | 272.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 97.20M |
| December 31, 2019 | -123.90M |
| September 30, 2019 | 557.40M |
| June 30, 2019 | 279.70M |
| March 31, 2019 | 331.30M |
| December 31, 2018 | 364.20M |
| September 30, 2018 | 199.10M |
| June 30, 2018 | 280.10M |
| March 31, 2018 | 82.20M |
| December 31, 2017 | 468.70M |
| September 30, 2017 | 321.40M |
| June 30, 2017 | 240.10M |
| March 31, 2017 | 152.50M |
| December 31, 2016 | 374.60M |
| September 30, 2016 | 183.70M |
| June 30, 2016 | 282.50M |
| March 31, 2016 | 56.20M |
| December 31, 2015 | 299.50M |
| September 30, 2015 | 220.20M |
| June 30, 2015 | 327.60M |
| March 31, 2015 | -120.70M |
| December 31, 2014 | 143.40M |
| September 30, 2014 | 123.00M |
| June 30, 2014 | 159.20M |
| March 31, 2014 | 85.80M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 459.00M |
| DaVita, Inc. | 320.25M |
| OPKO Health, Inc. | -46.50M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 11.74M |